title: Long-term efficacy and safety of oral calcium as compared to A1(OH)3 as phosphate binders.
authors.affiliation: Service d'Hemodialyse, Hôpital Sud, CHU Amiens, France.
authors.forename: P
authors.initials: P
authors.lastname: Moriniere
authors.forename: C
authors.initials: C
authors.lastname: Hocine
authors.forename: B
authors.initials: B
authors.lastname: Boudailliez
authors.forename: S
authors.initials: S
authors.lastname: Belbrik
authors.forename: H
authors.initials: H
authors.lastname: Renaud
authors.forename: P F
authors.initials: PF
authors.lastname: Westeel
authors.forename: M C
authors.initials: MC
authors.lastname: Solal
authors.forename: A
authors.initials: A
authors.lastname: Fournier
mesh_terms: D000284:Administration, Oral; D000328:Adult; D000368:Aged; D000536:Aluminum Hydroxide / Q000009:adverse effects / Q000378:metabolism / Q000627:therapeutic use*; D001847:Bone Diseases / Q000139:chemically induced; D002114:Calcinosis / Q000139:chemically induced; D002118:Calcium / Q000009:adverse effects / Q000378:metabolism / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D008276:Magnesium Hydroxide / Q000009:adverse effects / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D010710:Phosphates / Q000378:metabolism*; D013997:Time Factors
chemical_list: D010710:Phosphates; D000536:Aluminum Hydroxide; D008276:Magnesium Hydroxide; D002118:Calcium